CELH
Celsius Holdings, Inc.
CELH has the edge over MTEX overall, supported by stronger fundamentals and stronger valuation.
MTEX
Mannatech, Incorporated
MTEX trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MTEX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Strong |
MTEX's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
MTEX PE Valuation
MTEX has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
MTEX Forward outlook
There aren't enough analyst estimates for MTEX to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over MTEX on earnings quality, reporting a profit while its opponent remains loss making.
MTEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.31 | +$0.56 |
| Q2 2026 | -$3.91 | -$1.86 |
| Q1 2026 | -$6.71 | -$6.60 |
| Q4 2025 | -$8.00 | -706% |
| Q3 2025 | -$0.87 | -$0.06 |
| Q2 2025 | -$2.05 | -$1.42 |
| Q1 2025 | -$0.11 | +$0.78 |
| Q4 2024 | $1.32 | +$2.52 |
MTEX lost $0.31 per share over the past year, a smaller loss than the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over MTEX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over MTEX on profitability, with a higher operating margin.
MTEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.9M | -15% |
| Q2 2026 | $26.7M | +3.8% |
| Q1 2026 | $24.9M | -6.2% |
| Q4 2025 | $26.6M | -8.2% |
| Q3 2025 | $29.2M | -8.1% |
| Q2 2025 | $25.7M | -7.4% |
| Q1 2025 | $26.6M | -9.6% |
| Q4 2024 | $29M | -11% |
MTEX's revenue has slid since its 2021 peak: $25M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.1% | -5.8 points |
| Q2 2026 | 3.7% | +9.4 points |
| Q1 2026 | -0.7% | +2.4 points |
| Q4 2025 | -0.6% | -3.6 points |
| Q3 2025 | 6.9% | +4.1 points |
| Q2 2025 | -5.6% | -1.5 points |
| Q1 2025 | -3.1% | -5.9 points |
| Q4 2024 | 3% | +5.7 points |
MTEX's operating margin was 1.1% last quarter, down 5.8 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with MTEX at down 60%.
MTEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$802K | +$3.1M |
| Q1 2026 | $997K | +$2.9M |
| Q4 2025 | -$463K | -$350K |
| Q2 2025 | -$3.9M | -$1.1M |
| Q1 2025 | -$1.9M | -202% |
| Q4 2024 | -$113K | +$1.4M |
| Q3 2024 | $3M | +2882% |
| Q2 2024 | -$2.7M | +$189K |
MTEX has burned cash in six of the last eight quarters: −$648,000 over the past year, against −$3M the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over MTEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
MTEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +1.5% | +29K shares |
| 3 years | +3.6% | +67K shares |
| 5 years | -5% | -101K shares |
| Available history | -21% | -511K shares |
MTEX has 2M diluted shares, up 1.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $78,000 |
| Q2 2023 | $98,000 |
| Q1 2023 | — |
| Q4 2022 | $411,000 |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
MTEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q1 2025 | -5.2x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -6.5x | Net Cash |
| Q2 2024 | -8.4x | Net Cash |
| Q1 2024 | -9.2x | Net Cash |
| Q4 2023 | -11.3x | Net Cash |
| Q2 2023 | -38.3x | Net Cash |
MTEX has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
MTEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.4 | Neutral |
| Stochastic | 77.7 | Neutral |
MTEX's weekly RSI is 61 (neutral) and its Stochastic is 78 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
MTEX PE vs Consumer Defensive Sector
| Metric | MTEX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
MTEX has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
MTEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.91 | 14% above |
| 20 week MA | $6.78 | 32% above |
| 50 week MA | $6.63 | 35% above |
| 100 week MA | $8.30 | 8.2% above |
| 200 week MA | $9.34 | 3.9% below |
MTEX has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
MTEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.1 | $17.9 | +11% |
| 2021 | $17.9 | $36.8 | +105% |
| 2022 | $36.8 | $18.8 | -49% |
| 2023 | $18.8 | $8.10 | -57% |
| 2024 | $8.10 | $11.0 | +36% |
| 2025 | $11.0 | $7.66 | -30% |
| 2026 YTD | $7.66 | $8.98 | +17% |
MTEX has the edge over CELH on returns for 2026, with the stronger performance.